Suggestions
Hugo Saavedra
Bridging the cancer care gap
Hugo Saavedra is the Co-Founder and Chief Executive Officer of KYAN Technologies, a biotech company focused on precision medicine and cancer care.4 Here are some key details about Hugo Saavedra:
Professional Background
Hugo Saavedra joined KYAN Technologies as CEO in January 2022.2 He has extensive leadership experience across various industries, including consumer goods, consulting, and pharmaceuticals.1
Previous Roles::
- Chief Commercial Officer at Hello Health Group (2020-2021)
- VP & Regional General Manager of Latin America at Mundipharma (2019-2020)
- General Manager for Mundipharma in Brazil (2017-2018) and Thailand (2015-2017)
- Head of Marketing and Innovation for Emerging Markets at Mundipharma (2014-2015)
- Strategy Consulting at EffectiveBrands (2012-2014)
- Brand Management at Unilever (2008-2012)2
Education
- MBA from Thunderbird School of Global Management (2007-2009)
- Bachelor of Science in International Business and Marketing from Elmira College (2000-2004)
- Executive Education in General Management from INSEAD (2016-2017)2
Role at KYAN Technologies
As CEO of KYAN Technologies, Hugo Saavedra leads the company in its mission to revolutionize cancer care through the use of advanced technology and expertise.4 KYAN Technologies develops Optim.AI™, a platform that combines small data AI and wet lab biology to identify and rank combination treatments for cancer patients.3
Personal Background
Hugo Saavedra is originally from Brazil but has lived and worked across the United States, Latin America, and Asia for over 20 years.1 He is described as an energetic leader adept at creating clear vision and building successful teams.1
